Arvinas, Inc. engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC)
Market Cap | 1.594 Billion | Shares Outstanding | 53.228 Million | Avg 30-day Volume | 444.522 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -3.82 |
Price to Revenue | 21.0951 | Debt to Equity | 0.0016 | EBITDA | -230.9 Million |
Price to Book Value | 3.8083 | Operating Margin | -222.72729999999999 | Enterprise Value | 1.092 Billion |
Current Ratio | 5.334 | EPS Growth | -0.245 | Quick Ratio | 5.223 |
1 Yr BETA | 1.6383 | 52-week High/Low | 75.39 / 26.57 | Profit Margin | -225.0446 |
Operating Cash Flow Growth | -142.0394 | Altman Z-Score | 1.4858 | Free Cash Flow to Firm | -264.306 Million |
Earnings Report | 2023-05-04 |
Please sign in first
none
8.7 Thousand total shares from 3 transactions
25 Thousand total shares from 3 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
CASSIDY SEAN A CHIEF FINANCIAL OFFICER |
|
183,618 | 2023-03-01 | 2 |
TAYLOR IAN CHIEF SCIENTIFIC OFFICER |
|
101,721 | 2023-03-01 | 3 |
HOUSTON JOHN G PRESIDENT AND CEO |
|
917,427 | 2023-03-01 | 2 |
PECK RONALD CHIEF MEDICAL OFFICER |
|
27,279 | 2023-02-22 | 3 |
|
0 | 2022-12-15 | 2 | |
LOOMIS DAVID K CHIEF ACCOUNTING OFFICER |
|
2,750 | 2022-12-15 | 1 |
|
24,572 | 2022-08-18 | 2 | |
|
10,192 | 2022-06-16 | 1 | |
|
10,192 | 2022-06-16 | 1 | |
|
10,192 | 2022-06-16 | 1 | |
|
10,192 | 2022-06-16 | 1 | |
|
10,192 | 2022-06-16 | 1 | |
|
10,192 | 2022-06-16 | 1 | |
|
10,192 | 2022-06-16 | 2 | |
|
10,192 | 2022-06-16 | 1 | |
|
10,192 | 2022-06-16 | 1 | |
|
No longer subject to file | 2020-10-14 | 0 | |
|
0 | 2020-06-03 | 0 | |
|
1,775 | 2019-09-24 | 0 | |
|
3,316,059 | 2019-09-16 | 0 | |
CREW ANDREW SEE REMARKS |
|
0 | 2019-03-01 | 0 |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) DEERFIELD SPECIAL SITUATIONS FUND, L.P. |
|
No longer subject to file | 2018-10-01 | 0 |
|
No longer subject to file | 2018-10-01 | 0 | |
|
0 | 2018-09-26 | 0 | |
|
0 | 2018-09-26 | 0 | |
|
0 | 2018-09-26 | 0 | |
|
0 | 2018-09-26 | 0 | |
|
560,000 | 2018-09-26 | 0 | |
|
538,461 | 2018-09-26 | 0 | |
|
2,106,692 | 2018-09-26 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-03 21:49:25 -0500 | 2023-03-01 | S | 1,745 | $29.53 | d | 183,618 | direct | -2.1029 | -7.5057 | 0.0 | 1 | -12.5526 | 5 | |||
2023-03-03 21:51:13 -0500 | 2023-03-01 | M | 2,685 | d | 0 | direct | ||||||||||
2023-03-03 21:51:13 -0500 | 2023-03-01 | M | 2,685 | a | 102,772 | direct | -2.1029 | -7.5057 | 0.0 | 1 | -12.5526 | 5 | ||||
2023-03-03 21:51:13 -0500 | 2023-03-01 | S | 1,051 | $29.53 | d | 101,721 | direct | -2.1029 | -7.5057 | 0.0 | 1 | -12.5526 | 5 | |||
2023-03-03 21:50:14 -0500 | 2023-03-01 | M | 17,510 | d | 0 | direct | ||||||||||
2023-03-03 21:50:14 -0500 | 2023-03-01 | M | 17,510 | a | 923,305 | direct | -2.1029 | -7.5057 | 0.0 | 1 | -12.5526 | 5 | ||||
2023-03-03 21:50:14 -0500 | 2023-03-01 | S | 5,878 | $29.53 | d | 917,427 | direct | -2.1029 | -7.5057 | 0.0 | 1 | -12.5526 | 5 | |||
2023-03-03 21:49:25 -0500 | 2023-03-01 | M | 4,791 | d | 0 | direct | ||||||||||
2023-03-03 21:49:25 -0500 | 2023-03-01 | M | 4,791 | a | 185,363 | direct | -2.1029 | -7.5057 | 0.0 | 1 | -12.5526 | 5 | ||||
2023-02-24 16:56:46 -0500 | 2023-02-22 | A | 19,125 | a | 100,087 | direct | 0.2617 | 1.1122 | 2.6824 | 5 | -0.5561 | 4 | ||||
2023-02-24 16:59:35 -0500 | 2023-02-22 | A | 57,450 | a | 57,450 | direct | ||||||||||
2023-02-24 16:59:35 -0500 | 2023-02-22 | A | 19,125 | a | 180,572 | direct | 0.2617 | 1.1122 | 2.6824 | 5 | -0.5561 | 4 | ||||
2023-02-24 16:57:43 -0500 | 2023-02-22 | A | 186,250 | a | 186,250 | direct | ||||||||||
2023-02-24 16:57:43 -0500 | 2023-02-22 | A | 61,975 | a | 905,795 | direct | 0.2617 | 1.1122 | 2.6824 | 5 | -0.5561 | 4 | ||||
2023-02-24 16:58:36 -0500 | 2023-02-22 | A | 57,450 | a | 57,450 | direct | ||||||||||
2023-02-24 16:58:36 -0500 | 2023-02-22 | A | 19,125 | a | 27,279 | direct | 0.2617 | 1.1122 | 2.6824 | 5 | -0.5561 | 4 | ||||
2023-02-24 16:56:46 -0500 | 2023-02-22 | A | 57,450 | a | 57,450 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ARVINAS INC ARVN | 2023-03-20 13:45:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-20 13:15:04 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-20 12:45:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 22:15:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 21:45:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 21:15:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 20:45:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 20:15:06 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 19:45:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 19:15:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 18:45:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 18:15:03 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 17:45:04 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 17:15:05 UTC | 4.16 | 0.41 | 700000 |
ARVINAS INC ARVN | 2023-03-17 16:45:03 UTC | 4.1402 | 0.4298 | 700000 |
ARVINAS INC ARVN | 2023-03-17 16:15:04 UTC | 4.1402 | 0.4298 | 700000 |
ARVINAS INC ARVN | 2023-03-17 15:45:04 UTC | 4.1402 | 0.4298 | 700000 |
ARVINAS INC ARVN | 2023-03-17 15:15:03 UTC | 4.1402 | 0.4298 | 700000 |
ARVINAS INC ARVN | 2023-03-17 14:45:03 UTC | 4.1402 | 0.4298 | 700000 |
ARVINAS INC ARVN | 2023-03-17 14:15:04 UTC | 4.1402 | 0.4298 | 700000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND | ARVN | -93914.0 shares, $-3212797.94 | 2022-12-31 | N-PORT |